Tekin Guney
Overview
Explore the profile of Tekin Guney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koca U, Sahiner E, Kosemehmetoglu O, Guney T, Erismis B
Eur J Intern Med
. 2025 Feb;
PMID: 39966046
No abstract available.
2.
Can F, Yilmaz K, Kosemehmetoglu O, Akinci S, Guney T
Ann Hematol
. 2023 Jul;
102(10):2645-2650.
PMID: 37432415
Iron deficiency anemia is the most common and preventable cause of anemia. Oral and parenteral iron preparations can be used for treatment. There are some concerns about the effect on...
3.
Arslan Davulcu E, Demirci Z, Yilmaz U, Ar M, Uskudar Teke H, Karakus V, et al.
Indian J Hematol Blood Transfus
. 2023 Jan;
39(1):107-115.
PMID: 36699428
Acquired hemophilia A (AHA) is a rare disease caused by autoantibodies inhibiting factor VIII (FVIII) activity. Although the conditionis usually idiopathic, there may be other underlying diseases. Treatment consists of...
4.
Akdeniz A, Unuvar A, Ar M, Pekpak E, Akyay A, Mehtap O, et al.
Scand J Clin Lab Invest
. 2021 Dec;
82(1):28-36.
PMID: 34915774
Introduction: Inherited factor VII (FVII) deficiency (FVIID) is the most common of inherited rare bleeding disorders. Other determinants of clinical severity apart from FVII level (FVIIL) include genetic and environmental...
5.
Guney T, Can F, Akinci S, Kosemehmetoglu O, Dilek I
Turk J Haematol
. 2021 Dec;
39(1):74-75.
PMID: 34886748
No abstract available.
6.
Guney T, Can F, Alkan A, Akinci S, Dilek I
Clin Hemorheol Microcirc
. 2021 Oct;
80(3):233-240.
PMID: 34602461
Introduction: Essential thrombocythemia (ET) is an entity of classic Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs), characterized by thrombocytosis with megakaryocytic hyperplasia where in the thrombocytes are increased with abnormal function.Thrombotic events...
7.
Can F, Gokce D, Guney T, Akinci S, Dilek I
Balkan Med J
. 2021 Jun;
38(3):194.
PMID: 34142962
No abstract available.
8.
Gemici A, Ozkalemkas F, Dogu M, Tekinalp A, Alacacioglu I, Guney T, et al.
Clin Lymphoma Myeloma Leuk
. 2021 Jun;
21(8):e686-e692.
PMID: 34059487
Introduction: Venetoclax is a selective B-cell lymphoma 2 (BCL2) inhibitor, which is approved to treat elderly patients with newly diagnosed acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) in...
9.
Akdi A, Ozeke O, Karanfil M, Goktug Ertem A, Yayla C, Demirtas K, et al.
Blood Press Monit
. 2020 Jan;
25(2):69-74.
PMID: 31913148
Aims: Polycythemia vera increases the risk of hypertension, but there is limited information about the effect on daily blood pressure fluctuations. This study aimed to demonstrate how diurnal blood pressure...
10.
Guney T, Kanat I, Alkan A, Alisik M, Akinci S, Silay K, et al.
Redox Rep
. 2016 May;
22(6):246-251.
PMID: 27198712
Objectives: The etiology of multiple myeloma (MM) is not exactly known. This study investigated the role of thiol/disulfide homeostasis in the etiopathogenesis of MM. Methods: Some 50 patients with MM...